rss
Gut 53:1844-1849 doi:10.1136/gut.2003.036517
  • Liver

Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats

Table 1

 Heart rate and mean arterial pressure in the three groups of rats with cirrhosis

Heart rate (beats/min) Mean arterial pressure (mm Hg)
Control (n = 3) LPS (n = 4) LPS + tezosentan (n = 6) Control (n = 3) LPS (n = 4) LPS + tezosentan (n = 6)
Measurements were performed every 15 minutes (results are presented as mean for one hour).
Cirrhotic rats received either lipopolysaccharide (LPS) or placebo at one hour and tezosentan or placebo at two hours.
Control group, rats received placebo and placebo; LPS group, rats received LPS and placebo; LPS + tezosentan group, rats received LPS and tezosentan.
Values are mean (SEM).
*Significantly different from the control group; †significantly different from the LPS group.
0–1 h 352 (13) 388 (21) 368 (8) 97 (2) 95 (3) 103 (3)
1–2 h 351 (11) 400 (24)* 425 (6)* 102 (5) 78 (4)* 92 (4)†
2–3 h 372 (22) 397 (18) 411 (16) 104 (5) 86 (1)* 87 (3)*
3–4 h 347 (4) 389 (30) 415 (10)* 99 (5) 94 (7) 92 (5)
4–5 h 345 (10) 389 (31) 425 (10)* 103 (2) 93 (10) 91 (8)

This Article

Latest from Gut Education

Latest from Gut Education

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Gut.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.